Trial intelligence / Profile preview

Video Games and BoNT-A for Spastic Cerebral Palsy

NCT04290169Unknown

Sponsor
Sunnaas Rehabilitation Hospital
Start
Feb 2020
Primary completion
Mar 2022
Modality
Recombinant Proteins and Enzymes
01

Overview

Open-label, single-arm trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Sunnaas Rehabilitation Hospital. Primary endpoint: Goal Attainment Scale at 9 months. Status: unknown.

02

Drugs

botulinum toxin type A
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on NCT04290169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04290169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call